139 related articles for article (PubMed ID: 8991797)
1. Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptors.
Ukai M; Kobayashi T; Mori K; Shinkai N; Sasaki Y; Kameyama T
Eur J Pharmacol; 1995 Dec; 287(3):245-9. PubMed ID: 8991797
[TBL] [Abstract][Full Text] [Related]
2. Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, impairs memory consolidation in mice.
Ukai M; Mori K; Hashimoto S; Kobayashi T; Sasaki Y; Kameyama T
Eur J Pharmacol; 1993 Aug; 239(1-3):237-40. PubMed ID: 7901029
[TBL] [Abstract][Full Text] [Related]
3. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
4. Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in mice.
Ukai M; Monma J; Shinkai N; Sasaki Y; Kameyama T
Gen Pharmacol; 1997 Sep; 29(3):453-6. PubMed ID: 9378255
[TBL] [Abstract][Full Text] [Related]
5. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
6. Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice.
Ukai M; Watanabe Y; Kameyama T
Eur J Pharmacol; 2001 Jun; 421(2):115-9. PubMed ID: 11399267
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit.
Niijima F; Tan-No K; Esashi A; Nakagawasai O; Tadano T; Takahashi N; Yonezawa A; Sakurada S; Kisara K
Peptides; 2000 Feb; 21(2):295-9. PubMed ID: 10764959
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
Negri L; Noviello L; Noviello V
Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
[TBL] [Abstract][Full Text] [Related]
9. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
[TBL] [Abstract][Full Text] [Related]
10. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
12. Identification of the opioid receptors involved in passive-avoidance learning in the day-old chick during the second wave of neuronal activity.
Freeman FM; Young IG
Brain Res; 2000 May; 864(2):230-9. PubMed ID: 10802030
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of mu 1-opioid receptors in dermorphin tetrapeptide analogues-induced antinociception.
Mizoguchi H; Yuhki M; Watanabe H; Hayashi T; Sakurada C; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2004 Feb; 486(1):19-24. PubMed ID: 14751403
[TBL] [Abstract][Full Text] [Related]
14. Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA.
Mizoguchi H; Watanabe C; Osada S; Yoshioka M; Aoki Y; Natsui S; Yonezawa A; Kanno S; Ishikawa M; Sakurada T; Sakurada S
Psychopharmacology (Berl); 2010 Oct; 212(2):215-25. PubMed ID: 20683583
[TBL] [Abstract][Full Text] [Related]
15. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
16. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Yonezawa A; Sato T; Komatsu T; Sakurada T; Sakurada S
Eur J Pharmacol; 2011 Jan; 651(1-3):66-72. PubMed ID: 21047509
[TBL] [Abstract][Full Text] [Related]
18. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
20. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
